|
2001 - 2005 - Co-Investigator
Patient Examination with MelaFindTM system developed by Electro-Optical Sciences, Inc. (EOS)
Source: University of Michigan
Research Activities
2003 - ongoing - Co-Investigator
Topical Retinoids for Diabetic Foot Ulcers. Member, NIDDK Data and Safety Monitoring Plan.
Principal Investigator: James Varani, Ph.D..
Source: NIH/NIDDK Grant DK59169
5/2003 - 6/2003 - Co-Investigator
A phase II multi-center study of the safety and efficacy of adalimumab (D2E7) in subjects with moderate to severe chronic plaque psoriasis
Local principal investigator: Sewon Kang, M.D.
Source: Abbott Co.
2003 - ongoing - Co-Investigator
A Phase III Randomized Double - Blind Pivotal Trial of Immunotherapy with BCG Plus a Polyvalent Melanoma Vaccine, CancerVAXTM Vaccine Versus BCG Plus a Placebo as a Post - Surgical Treatment for Stage III Melanoma
Principal Investigator: Michael Sabel, M.D.
Source: University of Michigan
2003 - ongoing - Co-Investigator
Sunbelt Melanoma Trial (SMT): A multicenter trial of adjuvant interferon alpha - 26 for melanoma patients with early lymph node metastasis detected by lymphatic mapping and sentinel lymph node biopsy
Local principal investigator: Michael Sabel, M.D.
2001 - ongoing - Co-Investigator
Molecular, biochemical, and cellular basis of melanoma and other melanocytic lesions: Tissue Bank Principal Investigator: Timothy M. Johnson, M.D.
Source: University of Michigan
2000 - 2001 - Co-Investigator
Genes, environment and melanoma (GEM) study (Mulicenter collaborative investigation)
Local principal investigator: Stephen B. Gruber, M.D., Ph.D., MPH
9/92 - 12/92 - Co-Investigator
Specific localization of the malignant clone to the epidermal compartment in cutaneous T - cell lymphoma
Principal Investigator: David P. Fivenson, M.D.
3/91 - 10/91 - Co-Principal Investigator
An ultrastructural and clinical study of carbon dioxide laser excision of actinic cheilitis
4/90 - 6/90 - Co-Investigator
A multicenter, double - blind vehicle controlled study of topical 5% spironolactone cream in the treatment of nodulocystic acne
Principal Investigator: Adelaide Hebert, M.D.
Source: Searle
1/90 - 6/90 - Co-Investigator
A multicenter, double - blind evaluation of recombinant human basic fibroblast growth factory in the treatment of venous stasis and diabetic ulcers
Principal Investigator: Adelaide Hebert, M.D.
Source: Synergen, Inc.
7/88 - 12/89 - Co-Investigator
A bacteriologically controlled randomized, open - label study comparing the safety and efficacy of mupirocin with oral cephalexin in the treatment of patients with secondarily infected skin ulcers
Principal Investigator: Adelaide Hebert, M.D.
Source: Beecham Laboratories
7/88 - 10/88 - Co-Investigator
Safety and efficacy of once - daily 2% erythromycin/tretinoin 0.01% gel versus vehicle gel, erythromycin 2% gel and tretinoin 0.01% gel in acne vulgaris
Principal Investigator: Adelaide Hebert, M.D.
Source: Hebert Laboratories
5/88 - 7/88 - Co-Investigator
An open - label trial of Actiderm dermatologic patch with triamcinolone 0.1% cream in the management of chronic plaques in psoriasis
Principal Investigator: Adelaide Hebert, M.D.
Source: Squibb
| 
